Form 4: Baxter International Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Alok Sonig, EVP, Group President, Pharma at Baxter International, disposed of shares to cover tax withholding obligations related to vested restricted stock units.
Summary
- On March 3, 2025, Alok Sonig, EVP, Group President, Pharma at Baxter International, disposed of 1,936 shares of common stock to cover tax obligations.
- The shares were sold at a price of $34.86 per share.
- This transaction resulted from the settlement of vested restricted stock units granted on March 1, 2023.
- Following the transaction, Sonig directly owns 111,171 shares of Baxter International.
- The total includes the automatic reinvestment of dividends.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction related to executive compensation and tax obligations, with no indication of positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is a common occurrence where executives sell shares to cover tax obligations arising from the vesting of stock awards.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale of shares by an executive to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/01/2023 | Date of grant for the restricted stock units that vested. |
| 03/03/2025 | Date of the transaction (stock sale to cover taxes). |
| 03/05/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.